# Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/low-sexual-interest-desire-andor-arousal-in-women-developing-drugs-for-treatment-guidance-for-industry/c2fadf0e-3e7e-4274-99c9-c81028d61542

> FDA guidance document: Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment Guidance for Industry. Issue date: October 25, 2016. Get complete insights and analysis.

---

## Details

- Title: Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2016-10-25
- Comment Close Date: 2016-12-25
- Last Changed: 2020-04-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-2817">FDA-2016-D-2817</a>

## Related Documents

- [Migraine:  Developing Drugs for Preventive Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-preventive-treatment/cd739d7c-f8ed-4a37-b16f-d6f3b9550a94)
- [Alcoholism:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/alcoholism-developing-drugs-for-treatment/5dd607ce-ea00-4415-bc0a-e05b7963322b)
- [Endogenous Cushing’s Syndrome: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/endogenous-cushings-syndrome-developing-drugs-for-treatment/c89a914f-8df3-4543-87dc-697dcbc10611)